Cargando…

Challenges in mass drug administration for treating lymphatic filariasis in Papua, Indonesia

BACKGROUND: The World Health Organization (WHO) Global Program to Eliminate Lymphatic Filariasis relies on mass drug administration (MDA) of two drugs annually for 4 to 6 years. The goal is to reduce the reservoir of microfilariae in the blood to a level insufficient to maintain transmission by the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bhullar, Navneet, Maikere, Jacob
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2928210/ https://www.ncbi.nlm.nih.gov/pubmed/20701744 http://dx.doi.org/10.1186/1756-3305-3-70

Ejemplares similares

Reduction in Acute Filariasis Morbidity during a Mass Drug Administration Trial to Eliminate Lymphatic Filariasis in Papua New Guinea
por: Tisch, Daniel J., et al.
Publicado: (2011)

Lymphatic filariasis in Papua New Guinea: distribution at district level and impact of mass drug administration, 1980 to 2011
por: Graves, Patricia M, et al.
Publicado: (2013)

The role of gender relations in uptake of mass drug administration for lymphatic filariasis in Alor District, Indonesia
por: Krentel, Alison, et al.
Publicado: (2018)

Qualitative analysis of the impact of a lymphatic filariasis elimination programme using mass drug administration on Misima Island, Papua New Guinea
por: Wynd, Shona, et al.
Publicado: (2007)

Comparison of the Impact of Annual and Semiannual Mass Drug Administration on Lymphatic Filariasis Prevalence in Flores Island, Indonesia
por: Supali, Taniawati, et al.
Publicado: (2019)

National Mass Drug Administration Costs for Lymphatic Filariasis Elimination
por: Goldman, Ann S., et al.
Publicado: (2007)

Impact of mass drug administration for elimination of lymphatic filariasis in Nepal
por: Ojha, Chet Raj, et al.
Publicado: (2017)

Assessment of factors related to individuals who were never treated during mass drug administration for lymphatic filariasis in Ambon City, Indonesia
por: Titaley, Christiana Rialine, et al.
Publicado: (2022)

Elimination of lymphatic filariasis: current perspectives on mass drug administration
por: Gyapong, John O, et al.
Publicado: (2018)

Sequential Modelling of the Effects of Mass Drug Treatments on Anopheline-Mediated Lymphatic Filariasis Infection in Papua New Guinea
por: Singh, Brajendra K., et al.
Publicado: (2013)

Assessing knowledge about lymphatic filariasis and the implementation of mass drug administration amongst drug deliverers in three districts/cities of Indonesia
por: Titaley, Christiana R., et al.
Publicado: (2018)

Factors determining noncompliance to mass drug administration for lymphatic filariasis elimination
por: Nujum, Zinia T, et al.
Publicado: (2012)

Cessation of Mass Drug Administration for Lymphatic Filariasis in Zanzibar in 2006: Was Transmission Interrupted?
por: Rebollo, Maria P., et al.
Publicado: (2015)

Evaluation of mass drug administration in the program to control imported lymphatic filariasis in Thailand
por: Toothong, Tanaporn, et al.
Publicado: (2015)

Population pharmacokinetic model of ivermectin in mass drug administration against lymphatic filariasis
por: Alshehri, Abdullah, et al.
Publicado: (2023)

Correction: Sequential Modelling of the Effects of Mass Drug Treatments on Anopheline-Mediated Lymphatic Filariasis Infection in Papua New Guinea
por: Singh, Brajendra K., et al.
Publicado: (2014)

The Health and Economic Burdens of Lymphatic Filariasis Prior to Mass Drug Administration Programs
por: Mathew, Christopher G, et al.
Publicado: (2020)

Impact of Three Rounds of Mass Drug Administration on Lymphatic Filariasis in Areas Previously Treated for Onchocerciasis in Sierra Leone
por: Koroma, Joseph B., et al.
Publicado: (2013)

The Impact of Repeated Rounds of Mass Drug Administration with Diethylcarbamazine Plus Albendazole on Bancroftian Filariasis in Papua New Guinea
por: Weil, Gary J., et al.
Publicado: (2008)

Modeling the Impact and Costs of Semiannual Mass Drug Administration for Accelerated Elimination of Lymphatic Filariasis
por: Stolk, Wilma A., et al.
Publicado: (2013)

Long-Lasting Insecticidal Nets Are Synergistic with Mass Drug Administration for Interruption of Lymphatic Filariasis Transmission in Nigeria
por: Eigege, Abel, et al.
Publicado: (2013)

Mass Drug Administration Coverage Evaluation Survey for Lymphatic Filariasis in Bagalkot and Gulbarga Districts
por: Patel, Prakash Kurubarahalli
Publicado: (2012)

WILL MASS DRUG ADMINISTRATION ELIMINATE LYMPHATIC FILARIASIS? EVIDENCE FROM NORTHERN COASTAL TANZANIA
por: PARKER, MELISSA, et al.
Publicado: (2013)

Are we nearly there yet? Coverage and compliance of mass drug administration for lymphatic filariasis elimination
por: Alexander, Neal D. E.
Publicado: (2015)

Maintaining effective mass drug administration for lymphatic filariasis through in-process monitoring in Sierra Leone
por: Hodges, Mary H, et al.
Publicado: (2012)

Assessment of lymphatic filariasis prior to re-starting mass drug administration campaigns in coastal Kenya
por: Njenga, Sammy M., et al.
Publicado: (2017)

Prevalence and risk factors associated with lymphatic filariasis in American Samoa after mass drug administration
por: Coutts, Shaun P., et al.
Publicado: (2017)

Risk factors for lymphatic filariasis and mass drug administration non-participation in Mandalay Region, Myanmar
por: Dickson, Benjamin F. R., et al.
Publicado: (2021)

A comparison of two tests for filarial antigenemia in areas in Sri Lanka and Indonesia with low-level persistence of lymphatic filariasis following mass drug administration
por: Yahathugoda, Thishan C., et al.
Publicado: (2015)

Safety and efficacy of mass drug administration with a single-dose triple-drug regimen of albendazole + diethylcarbamazine + ivermectin for lymphatic filariasis in Papua New Guinea: An open-label, cluster-randomised trial
por: Tavul, Livingstone, et al.
Publicado: (2022)

The Role of Personal Opinions and Experiences in Compliance with Mass Drug Administration for Lymphatic Filariasis Elimination in Kenya
por: Njomo, Doris W., et al.
Publicado: (2012)

Seroprevalence and Spatial Epidemiology of Lymphatic Filariasis in American Samoa after Successful Mass Drug Administration
por: Lau, Colleen L., et al.
Publicado: (2014)

Is mass drug administration against lymphatic filariasis required in urban settings? The experience in Kano, Nigeria
por: Pam, Dung D., et al.
Publicado: (2017)

Improved assessment of mass drug administration and health district management performance to eliminate lymphatic filariasis
por: Maroto-Camino, Carmen, et al.
Publicado: (2019)

Assessing factors influencing communities’ acceptability of mass drug administration for the elimination of lymphatic filariasis in Guyana
por: Niles, Reza A., et al.
Publicado: (2021)

Mass drug administration of ivermectin, diethylcarbamazine, plus albendazole compared with diethylcarbamazine plus albendazole for reduction of lymphatic filariasis endemicity in Papua New Guinea: a cluster-randomised trial
por: Laman, Moses, et al.
Publicado: (2022)

A Review of Factors That Influence Individual Compliance with Mass Drug Administration for Elimination of Lymphatic Filariasis
por: Krentel, Alison, et al.
Publicado: (2013)

Elimination of Lymphatic Filariasis: Mass Drug Administration in Endemic Areas of (Bidar District) Karnataka-2008
por: Ranganath, TS, et al.
Publicado: (2012)

COMMUNITY MEMBERS' PERCEPTIONS OF MASS DRUG ADMINISTRATION FOR CONTROL OF LYMPHATIC FILARIASIS IN RURAL AND URBAN TANZANIA
por: KISOKA, WILLIAM J., et al.
Publicado: (2016)

Mass Drug Administration for the Elimination of Lymphatic Filariasis — Port-au-Prince, Haiti, 2011–2012
por: Streit, Thomas, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_73d89mt11dkc9ig2cs2123226k